New UAB research demonstrates social factors that determine survival of younger patients with AML and present opportunities to improve outcomes.
Steven M. Rowe, M.D., MSPH, has been named director of the Gregory Fleming James Cystic Fibrosis Research Center in the UAB School of Medicine, effective Aug. 1.
UAB is set to open a mental health clinic July 20 that will improve access to care for those who identify as LGBTQ.
Monika M. Safford, M.D., helped shape the new Web tool for the National Diabetes Education Program, “Promoting Medication Adherence in Diabetes.”
Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
UAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.
The American College of Surgeons has again verified UAB as a Level I Trauma Center, a designation held by UAB since 1999.
In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock’s left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr® endobronchial valve.
Fairhope, Alabama, resident Hayden Olds came for a second opinion, and ended up finding the best treatment route.
Through the Alabama Study on Early Age-Related Macular Degeneration, UAB researchers seek to identify the specific characteristics that make some more prone to AMD.